OTC Healthcare in Iran
Euromonitor International's OTC Healthcare in Iran market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 102 | Publication date: Jun 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Pharmaceuticals one of Iran’s most important strategic industries
The domestic pharmaceuticals industry, which meets the majority of domestic demand, is one of the most important industries in Iran. Improvements to this industry have a direct affect on social improvement indicators in Iran thus constant effort is made to make improvements to it. Almost 70 pharmaceuticals companies in Iran in 2008 were able to meet production requirements for Iran in addition to exporting their products to other countries.
Relatively high level of consumption of medicinal products in Iran
Per capita volume consumption of medicinal products in Iran is high due to several reasons. The three main reasons are the common custom of self-medication, the culture of prescription-bound products and patients seeking recourse to different doctors for a single ailment or problem.
Price mark-up on medicinal products in 2008
In 2008, there was a high mark-up in pricing of domestic medicinal products in OTC Healthcare in Iran and there were various reasons for this. Firstly, there was a reduction in the governmental budget for such products. The government reduced its budget for medicinal products by limiting the subsidies it offers to pharmaceuticals companies, which meant that these companies, in turn, had to increase their product pricing in order to cover their expenses. Secondly, the cost of raw materials increased due to appreciation of the euro. Thirdly, there was a global increase in the cost of raw materials and finally, there were problems relating to international trade due to US-led action, which included sanctions on Iran.
Contraband medicinal products low in volume but high in value
A number of European medicinal products are smuggled into Iran on a regular basis and it is possible to find various products, even rare ones, outside of chemists/pharmacies outlets. Naser Khosro Street in Tehran is one of the most popular locations for the sale of contraband products. There is very little control over such illegal activity in Iran and there are often reports of deaths due to consumption of contraband products and products that have expired. In this regard the government detects the presence of expired medicines by tracking dealers in Naser Khosro Street. The pricing of rare medicinal products in this location is very high.
Sales to recover in constant value terms
Over the forecast period unit prices in OTC Healthcare are expected to continue to increase as a result of high inflation in Iran and to thus support forecast period constant value growth. The most dynamic main category in OTC Healthcare, in terms of forecast period constant value growth, is expected to be vitamins and dietary supplements.
Table of contents
OTC HEALTHCARE IN IRAN : MARKET INSIGHT
EXECUTIVE SUMMARY
Pharmaceuticals one of Iran’s most important strategic industries
Relatively high level of consumption of medicinal products in Iran
Price mark-up on medicinal products in 2008
Contraband medicinal products low in volume but high in value
Sales to recover in constant value terms
MARKET DATA
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Labelling
De-listing or de-reimbursement
Advertising
Distribution
Vitamins & Dietary Supplements Registration and Classification
Generics
DEFINITIONS
Summary 1 Research Sources
ANALGESICS
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Analgesics Company Shares by Value 2004-2008
Table 15 Analgesics Brand Shares by Value 2005-2008
Table 16 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 20 Sales of Decongestants by Type: Value 2003-2008
Table 21 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 24 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 29 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 30 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 31 Herbal vs Standard Digestive Remedies 2003-2008
Table 32 Digestive Remedies Company Shares by Value 2004-2008
Table 33 Digestive Remedies Brand Shares by Value 2005-2008
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 36 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 37 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 38 Herbal vs Standard Medicated Skin Care 2003-2008
Table 39 Medicated Skin Care Company Shares by Value 2004-2008
Table 40 Medicated Skin Care Brand Shares by Value 2005-2008
Table 41 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 42 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 43 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 44 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 46 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 47 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 48 Vitamins Brand Shares by Value 2005-2008
Table 49 Dietary Supplements Brand Shares by Value 2005-2008
Table 50 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
EYE CARE IN IRAN
Sector Data
Table 52 Sales of Eye Care by Subsector: Value 2003-2008
Table 53 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 54 Eye Care Company Shares by Value 2004-2008
Table 55 Eye Care Brand Shares by Value 2005-2008
Table 56 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 57 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
WOUND TREATMENTS IN IRAN
Sector Data
Table 58 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 59 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 60 Wound Treatments Company Shares by Value 2004-2008
Table 61 Wound Treatments Brand Shares by Value 2005-2008
Table 62 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 63 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
EAR CARE IN IRAN
Sector Data
Table 64 Sales of Ear Care: Value 2003-2008
Table 65 Sales of Ear Care: % Value Growth 2003-2008
Table 66 Ear Care Company Shares by Value 2004-2008
Table 67 Ear Care Brand Shares by Value 2005-2008
Table 68 Forecast Sales of Ear Care: Value 2008-2013
Table 69 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN IRAN
Headlines
Sector Data
Table 70 Sales of Adult Mouth Care: Value 2003-2008
Table 71 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 72 Adult Mouth Care Company Shares by Value 2004-2008
Table 73 Adult Mouth Care Brand Shares by Value 2005-2008
Table 74 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 75 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN IRAN
Sector Data
Table 76 Sales of Calming and Sleeping Products: Value 2003-2008
Table 77 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 78 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 79 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 80 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 81 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
EMERGENCY CONTRACEPTION IN IRAN
Sector Data
Table 82 Sales of Emergency Contraception: Value 2003-2008
Table 83 Sales of Emergency Contraception: % Value Growth 2003-2008
Table 84 Emergency Contraception Company Shares by Value 2004-2008
Table 85 Emergency Contraception Brand Shares by Value 2005-2008
Table 86 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 87 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013
ALBORZ DAROU CO
Strategic Direction
Key Facts
Summary 2 Alborz Darou Co: Key Facts
Summary 3 Alborz Darou Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 4 Alborz Darou Co: Competitive Position 2007
DAROU PAKHSH PHARMACEUTICAL MFG CO
Strategic Direction
Key Facts
Summary 5 Darou Pakhsh Pharmaceutical MFG Co: Key Facts
Summary 6 Darou Pakhsh Pharmaceutical MFG Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7 Darou Pakhsh Pharmaceutical MFG Co: Competitive Position 2007
DINEH IRAN CO
Strategic Direction
Key Facts
Table 88 Dineh Iran Co: Key Facts
Company Background
Production
Competitive Positioning
Summary 8 Dineh Iran Co: Competitive Position 2007
DR ABIDI PHARMACEUTICAL CO
Strategic Direction
Key Facts
Summary 9 Dr Abidi Pharmaceutical Co: Key Facts
Summary 10 Dr Abidi Pharmaceutical Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Dr Abidi Pharmaceutical Co: Competitive Position 2008
SINA DAROU LABORATORIES CO
Strategic Direction
Key Facts
Summary 12 Sina Darou Laboratories Co: Key Facts
Summary 13 Sina Darou Laboratories Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 14 Sina Darou Laboratories Co: Competitive Position 2007